Literature DB >> 15145303

The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy.

Joyce A Cramer1, David Blum, Kristina Fanning, Michael Reed.   

Abstract

This study assessed the impact of comorbid depression on health care utilization and health care coverage by people with epilepsy in US communities using a postal survey questionnaire. People with untreated depression used significantly more health resources of all types assessed with and without adjustment for seizure type, seizure recency, and days with epilepsy symptoms. The number of visits to medical doctors and psychiatrists differed significantly among people with no (N = 443), mild to moderate (N = 58), and severe (N = 148) symptoms of depression who were not receiving antidepressant treatment (all P < 0.001). People with current symptoms treated with antidepressants had more medical visits than people with no current symptoms ( P=0.016 ). People with current symptoms but not treated for depression had more medical and psychiatric visits than people with no current symptoms (both P = 0.001). These data highlight the impact of comorbid depression on health care utilization by people with epilepsy.

Entities:  

Mesh:

Year:  2004        PMID: 15145303     DOI: 10.1016/j.yebeh.2004.01.010

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  19 in total

1.  Serotonin and epilepsy: the story continues.

Authors:  Barry E Gidal
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

2.  Stochastic Curtailment of Questionnaires for Three-Level Classification: Shortening the CES-D for Assessing Low, Moderate, and High Risk of Depression.

Authors:  Niels Smits; Matthew D Finkelman; Henk Kelderman
Journal:  Appl Psychol Meas       Date:  2015-06-29

3.  Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy.

Authors:  Jaivir S Rathore; Lara E Jehi; Youran Fan; Sima I Patel; Nancy Foldvary-Schaefer; Maya J Ramirez; Robyn M Busch; Nancy A Obuchowski; George E Tesar
Journal:  Epilepsy Behav       Date:  2014-07-26       Impact factor: 2.937

4.  A Trial of Sertraline or Cognitive Behavior Therapy for Depression in Epilepsy.

Authors:  Frank G Gilliam; Kevin J Black; Jewell Carter; Kenneth E Freedland; Yvette I Sheline; Wei-Yann Tsai; Patrick J Lustman
Journal:  Ann Neurol       Date:  2019-08-15       Impact factor: 10.422

5.  Depression and epilepsy: a new perspective on two closely related disorders.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

6.  Managing depressive disorders in patients with epilepsy.

Authors:  Madhukar H Trivedi; Ben T Kurian
Journal:  Psychiatry (Edgmont)       Date:  2007-01

7.  Sociodemographic and clinical factors associated with depression in epilepsy.

Authors:  Alexander W Thompson; John W Miller; Wayne Katon; Naomi Chaytor; Paul Ciechanowski
Journal:  Epilepsy Behav       Date:  2009-02-20       Impact factor: 2.937

Review 8.  Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

Authors:  Andres M Kanner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

Review 9.  Depression in epilepsy: a systematic review and meta-analysis.

Authors:  Kirsten M Fiest; Jonathan Dykeman; Scott B Patten; Samuel Wiebe; Gilaad G Kaplan; Colleen J Maxwell; Andrew G M Bulloch; Nathalie Jette
Journal:  Neurology       Date:  2012-11-21       Impact factor: 9.910

Review 10.  Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it.

Authors:  Nathalie Jetté; Farnaz Amoozegar; Scott B Patten
Journal:  Neurol Clin Pract       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.